ARCHIVES

Former NIH Director Varmus calls for more oversight of conflicts, expresses surprise at growth of Title 42 program.

This article is from The Cancer Letter archive.

Vol. 30 No. 21 | May 21, 2004

Download PDF Visit The Full Archive

Related Articles

In Brief: Phil Amoruso Will Be The New NCI Executive Officer; DRCCA Board Okays CCN Extension

January 2, 1981

NCAB Committee To Propose Event Marking Cancer Act

August 2, 1991

Biotherapeutics Reports LAK/IL-2 Toxicity Reduced With Constant Infusion Of IL-2

April 17, 1987

NCAB Subcommittee Likes Organ Site Program, Except Smoking-Health

April 30, 1976

DCE Advisors OK Concepts for Registry, Grants In Breast Cancer

June 25, 1993

XGEVA not Inferior to Zometa In 1,776-Patient Phase III Study

March 25, 2011